- Previous Close
5.21 - Open
4.96 - Bid 6.05 x --
- Ask 5.99 x --
- Day's Range
4.91 - 6.42 - 52 Week Range
3.86 - 22.20 - Volume
181,627 - Avg. Volume
77,531 - Market Cap (intraday)
189.558M - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
-- - EPS (TTM)
-2.20 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
iXensor Co., Ltd. provides technology platform that turns smartphones into in vitro diagnostic devices through its smart color sensing technology for connected healthcare. The company's PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the immunoassay or colorimetric strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management; and PixoTest COVID-19 Rapid Antigen Test for infectious disease management, as well as PixoHealth Pass Admin app and Web portal. The company was founded in 2012 and is based in Taipei, Taiwan.
www.ixensor.comRecent News: 6734.TWO
View MorePerformance Overview: 6734.TWO
Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6734.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6734.TWO
View MoreValuation Measures
Market Cap
151.89M
Enterprise Value
175.04M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.44
Price/Book (mrq)
8.55
Enterprise Value/Revenue
10.35
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-52.29%
Return on Equity (ttm)
-316.72%
Revenue (ttm)
16.91M
Net Income Avi to Common (ttm)
-57.15M
Diluted EPS (ttm)
-2.20
Balance Sheet and Cash Flow
Total Cash (mrq)
13.18M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-28.53M